Skip to content

Wecare Study in Gastric Cancer Survivors

A Multi-center, Prospective, Randomized Study to Evaluate the Usefulness of Applying the Chronic Side Effect Management Platform (Wecare) in Gastric Cancer Survivors

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06395935
Enrollment
88
Registered
2024-05-02
Start date
2024-04-01
Completion date
2026-03-30
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In this study, we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support.

Detailed description

Smartphone apps have been gaining popularity in the delivery of lifestyle interventions in chronic disease management. In patients with cancer, randomized clinical trials have investigated the effect of smartphone-based interventions and reported improved quality of recovery and equal satisfaction with care compared with conventional in-person follow-up. However, there are no studies yet in which smartphone apps have evaluated the quality of life in patients after gastric cancer surgery. Surgery is the mainstay of gastric cancer treatment. The proportion of patients with early gastric cancer and their survival rate of gastric cancer patients are increasing in East Asia thanks to the nationwide endoscopy screening program. As the number of long-term survivors after gastric cancer surgery increases, interest in the quality of life after surgery is also increasing. After gastrectomy, the remaining stomach volume is reduced or lost, and the vagus nerve is damaged during the surgery, which has various effects on the motor function and hormone secretion function of the stomach. Patients experience postgastrectomy syndrome, which includes lethargy, decreased appetite, early satiety, weight loss, abdominal distension, gastroesophageal reflux symptoms, diarrhea, anemia, and dumping syndrome. In addition to these physical symptoms, patients experience various symptoms and aftereffects after stomach cancer surgery, including psychological reactions such as fear, anxiety, and depression, and social problems such as avoidance of interpersonal relationships, social isolation, and difficulty returning to society.

Interventions

OTHERWecare (website)

support feedback of qutionaire & supply educational contents

Sponsors

National Cancer Center, Korea
CollaboratorOTHER_GOV
Gyeongsang National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Adult patient (19-75 years) who underwent radical gastrectomy

Exclusion criteria

* Patients who were unable to undergo regular follow-up, lacked communication, or were deemed unsuitable to participate in this study by the researcher

Design outcomes

Primary

MeasureTime frameDescription
the quality of life in gastric cancer survivor (KOQUSS-40)at 1, 3, and 6 months after surgery in the outpatient clinic.KOQUSS-40 questionnaire has a 40-item questionnaire in 11 domains focusing on the symptoms evaluation after gastric cancer surgery.

Secondary

MeasureTime frameDescription
nutritional indexat 1, 3, and 6 months after surgery in the outpatient clinic.nutritional index change
KOQUSS-40 questionnaire complianceat 1, 3, and 6 months after surgery in the outpatient clinic.check the KOQUSS-40 questionnaire compliance
Weightat 1, 3, and 6 months after surgery in the outpatient clinic.Weight change

Countries

South Korea

Contacts

Primary ContactSook-Ran Park
sr0218@naver.com+82552142318

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026